ArticleAsian journal of urology2025
Laparoendoscopic single-site robot-assisted nephroureterectomy: Comparison with the conventional multiport laparoendoscopic technique for upper tract urothelial carcinoma in the retroperitoneal approach.
Article in Asian journal of urology, 2025. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
0 citing papers in PubMed.
No citing paper in PubMed yet.
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
9 authors.
Funding
No grant is acknowledged in the PubMed record.
Abstract
Objective: To evaluate the feasibility and safety of laparoendoscopic single-site robot-assisted nephroureterectomy (LESS-RANU) by comparing perioperative, pathological, and oncological results with the conventional multiport laparoendoscopic approach in the retroperitoneal approach for the management of urinary tract urothelial carcinoma. Methods: Between January 2021 and October 2024, our center treated 56 patients with urinary tract urothelial carcinoma using either the LESS-RANU ( Results: No significant differences were found in patient demographics and tumor characteristics between the two groups. No serious intraoperative complications occurred in both groups. The mean operation time, skin incision length, Visual Analog Scale pain scores, time for repositioning and follow-up duration for the LESS-RANU group and the LNU group were 138.23 min and 180.40 min, 6.48 cm and 15.40 cm, 3.23 and 4.60, 5.71 min and 30.24 min, and 10.84 months and 22.88 months, respectively ( Conclusion: LESS-RANU is safe and more effective compared to LNU via the retroperitoneal approach, especially for patients with low body mass index.
Indexed as
Identifiers
What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.